Publicaciones (21) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. A mi amigo Enrique Reig

    MPJ Multidisciplinary Pain Journal, Núm. 1

  3. Association between sexual satisfaction and resilience in premenopausal women

    Revista de Obstetricia y Ginecologia de Venezuela, Vol. 82, Núm. 3, pp. 322-328

  4. Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review

    Diabetes Therapy, Vol. 13, pp. 19-34

  5. Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients*

    British Journal of Dermatology, Vol. 187, Núm. 6, pp. 962-969

  6. Delphi Consensus on Therapeutic Strategies and Health Prevention of hypovitaminosis D

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 115-124

  7. Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial

    Diabetes Therapy, Vol. 13, Núm. 4, pp. 761-774

  8. European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

    Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 3, pp. 332-350

  9. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  10. Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials

    Diabetes, Obesity and Metabolism, Vol. 24, Núm. 4, pp. 631-640

  11. Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539

  12. Histopathology of Dermatologic Complications of Tattoos

    American Journal of Dermatopathology, Vol. 44, Núm. 9, pp. 632-649

  13. Long-term use of ospemifene in clinical practice for vulvo-vaginal atrophy: end results at 12 months of follow-up

    Gynecological Endocrinology, Vol. 38, Núm. 7, pp. 577-582

  14. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  15. Results of a Hepatitis C Micro-Elimination Program in Two Addiction Centers Among Subjects With Substance Use Disorder

    Substance Abuse: Research and Treatment, Vol. 16

  16. Romosozumab efficacy and safety in European patients enrolled in the FRAME trial

    Osteoporosis International, Vol. 33, Núm. 12, pp. 2527-2536

  17. Severe hiperemesis gravidarum caused by Helicobacter pylori

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 2, pp. 91-92

  18. Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia

    Gynecologic Oncology Reports, Vol. 44

  19. TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society

    Actas espanolas de psiquiatria, Vol. 50, pp. 77-138

  20. Therapeutic approach in patients with complex regional pain syndrome: an update

    Revista de la Sociedad Espanola del Dolor, Vol. 29, Núm. 1, pp. 34-50